Skip to main content
Translational Pharmaceutics®

Quotient Sciences speaks with Outsourcing Pharma on what's ahead for CPhI

This article from Outsourcing Pharma describes how our team at Quotient Sciences is looking forward to reconnecting with customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US at CPhI North America.

Topics discussed include how we plan to stay ahead of industry trends and developments, recent partnerships and collaborations, challenges we are facing and how these are being addressed, future expansion plans, and insight into what sets us apart from industry competitors.

Read the full article here on the Outsourcing Pharma website.

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, John McDermott Quotient Sciences’ John McDermott Contributes to Pharmaceutical Outsourcing Oral Solid Dosage Roundtable By: John McDermott
Read More
News & Announcements, Articles & Publications, John McDermott Q&A with Quotient Sciences’ John McDermott: Exploring the Benefits of Partnering with a CRDMO By: John McDermott
Read More
News & Announcements, Articles & Publications, Translational Pharmaceutics®, Dr. Asma Patel, Matt Paterson Dr. Asma Patel and Matt Pa­terson contribute to Drug Development & Delivery's special feature, 'Outsourcing Formulation Development & Manufacturing' By: Dr. Asma Patel and Matt Paterson
Read More
Get in touch
Humanity can't afford to wait, so neither can we.